Teva Pharmaceutical Industries purchases Allergan's generics business for $40.5-billion. This may help generic-drug makers to acquire products that may be divested s part of the antitrust procedures in the US and fill their portfolio gaps. Teva ... MedIndia, 1 month ago
Teva-Allergan deal a booster for Indian companies - Economic Times, 1 month ago
Indian drug makers are readying a war chest to fund acquisitions that will help expand their product range, and give them access to new markets and distribution networks at home and overseas, their appetite having been whetted by a string of recent ...The Gulf Today, 1 month ago Indian pharma firms build a war chest for acquisitions Livemint.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!